AET - We Are Playing The CVS Hand
CVS Health (NYSE:CVS) was recently recommended as a top play at $60.50 to members of BAD BEAT Investing. The stock has caught our attention for a potential upside trade with longer-term appeal after reporting its earnings last week, which were quite interesting relative to our expectations. This name had been stuck in neutral for months, essentially range bound between $70-$80, with a few exceptions, until news that it was interested in purchasing Aetna (AET) surfaced, which sent the stock below $70, where it has been struggling ever since.
The